Related Experiment Videos
[Parathyroid function in hyperthyroidism: implications for bone metabolism and effect of the treatment]
R P Furlanetto1, M L Castro, C H de Mesquita
1Disc. de Endocrinologia, EPM, São Paulo.
Revista Paulista De Medicina
|March 1, 1991
Summary
Hyperthyroidism patients experience bone loss, evidenced by decreased bone mineral density and impaired parathyroid hormone (PTH) secretion. Treatment for hyperthyroidism reverses these bone density and PTH secretion abnormalities, suggesting a direct effect of thyroid hormones.
Area of Science:
- Endocrinology
- Bone Metabolism
Context:
- Hyperthyroidism, specifically toxic diffuse goiter (Graves' disease), is associated with bone loss.
- The role of parathyroid hormone (PTH) in this osteopenia is not fully understood.
Purpose:
- To evaluate bone loss in hyperthyroidism patients using bone densitometry.
- To investigate the potential contribution of parathyroid hormone (PTH) to osteopenia in hyperthyroidism.
- To assess changes in bone mineral density and PTH secretion before and after treatment.
Summary:
- A prospective study evaluated 14 hyperthyroidism patients, measuring bone mineral content via dual-photon bone densitometry and assessing PTH secretion after EDTA-induced hypocalcemia.
- Untreated patients showed significantly lower bone mineral density and a blunted PTH secretory reserve compared to 10 normal controls.
- After treatment and achieving euthyroidism for at least six months, bone mineral density significantly increased, and PTH secretion normalized.
Impact:
- Results indicate significant bone loss in hyperthyroidism, likely due to a direct effect of thyroid hormones, as evidenced by reduced PTH secretory capacity.
- Treatment effectively reverses bone loss and restores normal PTH function, highlighting the importance of managing hyperthyroidism for bone health.